您好,欢迎访问中国农业科学院 机构知识库!

SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor

文献类型: 外文期刊

作者: Zhang, Cuiling 1 ; Jiang, Qiwei 1 ; Liu, Zirui 1 ; Li, Nan 1 ; Hao, Zhuo 1 ; Song, Gaojie 2 ; Li, Dapeng 3 ; Chen, Minghua 1 ; Lin, Lisen 4 ; Liu, Yan 1 ; Li, Xiao 1 ; Shang, Chao 1 ; Li, Yiquan 5 ;

作者机构: 1.Chinese Acad Agr Sci, Changchun Vet Res Inst, Changchun, Peoples R China

2.Jiujiang Univ, Jiangxi Prov Key Lab Syst Biomed, Jiujiang, Peoples R China

3.First Hosp Jilin Univ, Dept Neurosurg, Changchun, Peoples R China

4.Northeastern Univ, Dept Chem, Shenyang, Peoples R China

5.Changchun Univ Chinese Med, Coll Integrat Med, Key Lab Jilin Prov Tradit Chinese Med Prevent & Tr, Changchun, Peoples R China

关键词: NSP6; autophagosomes; SIGMAR1; lysosome

期刊名称:JOURNAL OF VIROLOGY ( 影响因子:3.8; 五年影响因子:3.9 )

ISSN: 0022-538X

年卷期: 2024 年 98 卷 11 期

页码:

收录情况: SCI

摘要: Autophagy is a cellular self-defense mechanism by which cells can kill invading pathogenic microorganisms and increase the presentation of components of pathogens as antigens. Contrarily, pathogens can utilize autophagy to enhance their own replication. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) NSP6 can interact with ATPase proton pump component to inhibit lysosomal acidification, which was implicated in the autophagy process. However, research on how SARS-CoV-2 NSP6 affected autophagy, and its impact on virus replication is still lacking. Coronavirus NSP6 has been reported to promote coronavirus replication by limiting autophagosome expansion. However, this finding has not been confirmed in coronavirus disease 2019 (COVID-19). We investigated the effect of NSP6 protein on autophagosomes in different mutant strains of SARS-CoV-2 and revealed that the size of autophagosomes was reduced by NSP6 of the wild-type and Delta variant of SARS-CoV-2. In addition, we found that SARS-CoV-2 NSP6 localized to the lysosome and had an inhibitory effect on the binding of autophagosomes to the lysosome, which blocked the autophagy flux; this may be related to endoplasmic reticulum (ER)-related pathways. We also found that sigma-1 receptor (SIGMAR1) knock out (KO) reversed NSP6-induced autophagosome abnormality and resisted SARS-CoV-2 infection, which responds to the fact that SIGMAR1 is likely to be used as a potential target for the treatment of SARS-CoV-2 infection. In summary, we have provided a preliminary explanation of the effects on autophagy of the SARS-CoV-2 NSP6 protein from the pre-autophagic and late stages, and also found that SIGMAR1 is likely to be used as a potential target for SARS-CoV-2 therapy to develop relevant drugs.
IMPORTANCE We have provided a preliminary explanation of the effects on autophagy of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structure protein 6 from the pre-autophagic and late stages, and also found that sigma-1 receptor is likely to be used as a potential target for SARS-CoV-2 therapy to develop relevant drugs.

  • 相关文献
作者其他论文 更多>>